๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Evaluation and treatment of peroneal neuropathy

โœ Scribed by Jennifer Baima; Lisa Krivickas

Book ID
107617950
Publisher
Current Science Inc.
Year
2008
Tongue
English
Weight
241 KB
Volume
1
Category
Article
ISSN
1935-973X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Atypical deep peroneal neuropathy in the
Atypical deep peroneal neuropathy in the setting of an accessory deep peroneal nerve
โœ Rana Kayal; Bashar Katirji ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 84 KB

## Abstract We report a case of deep peroneal neuropathy resulting in foot drop with preserved toe extension. These unexpected findings were the result of the presence of an accessory deep peroneal nerve that provided total innervation of the extensor digitorum brevis. We review the literature on t

Accessory deep peroneal neuropathy: Coll
Accessory deep peroneal neuropathy: Collision technique diagnosis
โœ Howard W. Sander; Christine Quinto; Sudhansu Chokroverty ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 34 KB

Accessory deep peroneal nerve (ADPN), a common anatomic variant, is traditionally suspected when common peroneal nerve stimulation evokes a greater amplitude extensor digitorum brevis compound muscle action potential than deep peroneal nerve (DPN) stimulation. Posterolateral ankle stimulation over t

Evaluation of neuropathy in patients on
Evaluation of neuropathy in patients on suramin treatment
โœ Betty Soliven; Upinder K. Dhand; Ken Kobayashi; Ravinder Arora; Barbara Martin; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 125 KB

Suramin, a promising chemotherapeutic agent, causes a dose-limiting sensorimotor polyneuropathy. We undertook a phase 1 study of suramin that included serial neurologic and electrophysiologic examinations as part of the safety evaluation. We found that 6 of 41 (15%) patients developed suramininduced